Prosecution Insights
Last updated: April 19, 2026

Examiner: PAULUS, ERIN VIRGINIA

Tech Center 1600 • Art Units: 1631

This examiner grants 43% of resolved cases

Performance Statistics

42.9%
Allow Rate
-17.1% vs TC avg
44
Total Applications
+80.0%
Interview Lift
821
Avg Prosecution Days
Based on 7 resolved cases, 2023–2026

Rejection Statute Breakdown

8.8%
§101 Eligibility
14.5%
§102 Novelty
34.8%
§103 Obviousness
32.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17936216 METHODS FOR IDENTIFYING A CELL UPTAKE MECHANISM Non-Final OA The Regents of the University of California
18170997 TARGETED DELIVERY OF DRUG MOLECULES WITH DRUG LIGANDS CONJUGATED TO RNA NANOPARTICLE MOTION ELEMENTS Non-Final OA Ohio State Innovation Foundation
18174096 METHOD OF RECOVERING CELLS AND CELL RECOVERY APPARATUS Non-Final OA CANON KABUSHIKI KAISHA
17502152 MODIFIED EXTRACELLULAR MATRIX-BASED HYDROGEL, MANUFACTURING METHOD OF THE SAME AND USE OF THE SAME Final Rejection POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
17774645 DROPLET DEFORMATION-BASED METHOD OF TRANSFERRING MATERIAL INTO CELLS AND CHIP FOR SAME Final Rejection Korea University Research and Business Foundation
18196402 EXPANDED VACUUM-STABLE GELS FOR MULTIPLEXED HIGH RESOLUTION SPATIAL HISTOPATHOLOGY Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18033639 MODIFIED SIGNAL PEPTIDE Non-Final OA KAO CORPORATION
17801408 COMPOSITION FOR INDUCING BROWNING, CONTAINING MILK EXOSOMES Final Rejection UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
17904023 METHOD FOR PRODUCING AVATAR MOUSE AS ATOPIC DERMATITIS ANIMAL MODEL AND USE THEREOF Final Rejection INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
17963601 NANOBARRIER AND METHOD OF REGULATING MACROPHAGE ADHESION AND POLARIZATION USING THE SAME Non-Final OA Industry-University Cooperation Foundation Hanyang University ERICA Campus
18466854 METHOD FOR ASSESSING RESPIRATORY VIRAL INFECTIONS Non-Final OA The University of Hong Kong
18262341 STEM CELL IN WHICH IMMUNE CELL TOLERANCE MODULATOR IS OVEREXPRESSED, AND USE THEREOF Non-Final OA UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
17904441 PLATELET PRODUCTION METHOD AND DEVICE Final Rejection KYOTO UNIVERSITY
18271503 PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS Non-Final OA Ecole Polytechnique Federale de Lausanne (EPFL)
18553292 REPROGRAMMING OF CELLS AND USES THEREOF Non-Final OA STEMCELL TECHNOLOGIES CANADA INC.
17753708 ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR MITIGATING DISEASE-INDUCED TISSUE DAMAGE Non-Final OA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
17876993 Method of Demineralizing Bone with an Ionic Solution Non-Final OA Newsouth Innovations Pty Limited
18424292 COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA Non-Final OA THE CHILDREN'S MEDICAL CENTER CORPORATION
17810982 PLASMODIUM VIVAX MALE GAMETE FUSION PROTEIN PVHAP2 AND THE PUTATIVE PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 AS RELAPSE BIOMARKERS Final Rejection Seattle Children's Hospital dba Seattle Children's Research Institute
17712452 BIOSYNTHESIS OF ALPHA-IONONE AND BETA-IONONE Non-Final OA Conagen Inc.
18268167 EXPANDED AND STIMULATED NATURAL KILLER CELLS Non-Final OA GC Cell Corporation
18247519 Advanced Cell-Permeable Peptide Carriers Non-Final OA MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
18043818 SQUALENE HOPENE CYCLASE DERIVATIVES AND USE THEREOF FOR PRODUCING AMBROX Non-Final OA INTERNATIONAL FLAVORS & FRAGRANCES, INC.
18257833 METHOD FOR OPTICALLY CLEARING A TISSUE SAMPLE USING AN EMBEDDING MEDIUM Non-Final OA MobiCron GmbH
17916340 METHOD FOR PREPARING CULTURE MEDIUM CONTAINING HIGH LEVELS OF HIGH-POTENCY EXOSOMES SECRETED BY CORD BLOOD STEM CELLS, AND USE THEREOF Non-Final OA PRIMORIS THERAPEUTICS Co., Ltd.
18252619 ENRICHED BIOACTIVE RENAL CELL POPULATIONS, CHARACTERISTICS AND USES THEREOF Non-Final OA ProKidney
18033470 METHODS FOR PROCESSING FETAL SUPPORT TISSUE Non-Final OA BioTissue Holdings Inc.
18157599 COMPOSITION AND METHOD FOR TREATING EYE DISEASES Non-Final OA Frontera Therapeutics, Inc.
17912953 METHOD FOR THE PRODUCTION AND PURIFICATION OF MULTIVALENT IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS Non-Final OA Ablynx NV
17295122 MARKER FOR DETECTING PROLIFERATION OF STEM CELL AND HIGH-EFFICIENCY PROLIFERATION METHOD OF STEM CELL USING SAME Non-Final OA Encell Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month